Italian Life Sciences Database

NORTHBROOK, Ill. and INDIANAPOLIS, Feb. 10, 2020 /PRNewswire/ -- The Astellas Global Health Foundation ("Foundation") and the Academic Model Providing Access to Healthcare (AMPATH), under the direction of the Indiana University Center for Global Health, announced today that the Foundation has... Read more ››

By: PR Newswire Association LLC. - 10 Feb 2020

Sanofi delivers strong 2019 business EPS growth of 6.8% at CER

By: GlobenewsWire - 06 Feb 2020

Sanofi : Sanofi brain-penetrant BTK inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis

By: GlobenewsWire - 06 Feb 2020

Novo Nordisk's operating profit increased by 11% in Danish kroner and by 6% at constant exchange rates (CER) in 2019

By: GlobenewsWire - 05 Feb 2020

ALK releases its 2019 annual report

By: GlobenewsWire - 05 Feb 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 04 Feb 2020

Q3 Medical Devices Leads the Way for Irish Companies Seeking to List on Hong Kong Exchange

DUBLIN, Feb. 3, 2020 /PRNewswire/ -- Q3 Medical Devices Limited ("Q3 Medical") based in Dublin, Ireland announced that the Hong Kong Stock Exchange (the "Exchange") has approved Ireland as an acceptable jurisdiction for the purpose of Irish companies seeking to list on the Exchange.... Read more ››

By: PR Newswire Association LLC. - 03 Feb 2020

Sanofi: Disclosure of trading in own shares

By: GlobenewsWire - 03 Feb 2020

Rybelsus® (oral semaglutide) recommended for approval for the treatment of adults with type 2 diabetes by the European regulatory authorities

By: GlobenewsWire - 31 Jan 2020

Sanofi : Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency

By: GlobenewsWire - 30 Jan 2020

Allergy Therapeutics publishes encouraging new data for peanut allergy vaccine candidate in The Journal of Allergy and Clinical Immunology

By: GlobenewsWire - 29 Jan 2020

Related companies: Allergy Therapeutics Italia S.R.L. | Allergy Therapeutics plc | Allergy Therapeutics Ibérica, SL

Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

By: GlobenewsWire - 28 Jan 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 27 Jan 2020

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Italy?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

June 2020
- Digital RESI – Three Day Conference
- BIO Digital
- Brussels: The Pharma Business Development Course

See Events »

Add an Event »

Latest company news

SI-BONE, Inc. Announces $40 Million Debt Re-Financing
01 Jun 2020 (GlobenewsWire)

Sanofi announces closing of Regeneron stock sale
29 May 2020 (GlobenewsWire)

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time
29 May 2020 (GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of Italy?

Partners

Upcoming Life Sciences Events

Latest company news